OVERSEA CHINESE BANKING Corp Ltd Has $38.66 Million Stock Position in Agilent Technologies, Inc. (NYSE:A)

OVERSEA CHINESE BANKING Corp Ltd lessened its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 12.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 260,393 shares of the medical research company's stock after selling 37,992 shares during the period. Agilent Technologies comprises approximately 1.1% of OVERSEA CHINESE BANKING Corp Ltd's portfolio, making the stock its 21st biggest position. OVERSEA CHINESE BANKING Corp Ltd owned about 0.09% of Agilent Technologies worth $38,663,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Livelsberger Financial Advisory bought a new position in Agilent Technologies during the third quarter valued at about $28,000. Crewe Advisors LLC boosted its holdings in Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company's stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in Agilent Technologies during the third quarter valued at approximately $31,000. Ridgewood Investments LLC acquired a new stake in Agilent Technologies during the second quarter valued at approximately $29,000. Finally, Fortitude Family Office LLC boosted its holdings in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock valued at $35,000 after purchasing an additional 95 shares in the last quarter.

Agilent Technologies Stock Up 0.0 %

Shares of NYSE A traded up $0.02 during mid-day trading on Tuesday, hitting $133.88. The company had a trading volume of 547,677 shares, compared to its average volume of 1,700,114. The company has a market capitalization of $38.47 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 6.01 and a beta of 1.07. The firm has a 50-day simple moving average of $139.27 and a two-hundred day simple moving average of $138.19. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a one year low of $106.96 and a one year high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies's revenue was down 5.6% on a year-over-year basis. During the same period last year, the business posted $1.43 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were given a $0.236 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. Agilent Technologies's payout ratio is 19.50%.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now directly owns 24,118 shares of the company's stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares of the company's stock, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the business's stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock valued at $1,739,510 over the last three months.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on A. Evercore ISI boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an "in-line" rating in a report on Tuesday, October 1st. Stifel Nicolaus reissued a "buy" rating and issued a $151.00 target price on shares of Agilent Technologies in a report on Monday, August 26th. TD Cowen upped their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a "buy" rating in a report on Thursday, August 22nd. Barclays upped their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an "underweight" rating in a report on Tuesday, October 15th. Finally, Citigroup upped their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a "buy" rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $144.36.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.